Early immunotherapy shows strong responses in advanced basal cell carcinoma
Johns Hopkins Medicine - 18-Nov-2025First-line nivolumab doubles typical response rates in inoperable basal cell carcinoma
Join the club for FREE to access the whole archive and other member benefits.
Johns Hopkins Kimmel Cancer Center is a world-leading institution advancing cancer research
The Johns Hopkins Kimmel Cancer Center is a world-renowned institution dedicated to cancer research, treatment, and education. Based at Johns Hopkins Medicine in Baltimore, Maryland, the center has earned a reputation as a leader in oncology for its groundbreaking research, comprehensive patient care, and commitment to translating scientific discoveries into real-world therapies.
Named after philanthropist Sidney Kimmel, who made a transformative donation to the center, the Kimmel Cancer Center is one of only a few cancer centers in the United States designated as a Comprehensive Cancer Center by the National Cancer Institute. This designation reflects the center’s excellence across laboratory research, clinical trials, population science, and education.
Visit website: https://www.hopkinsmedicine.org/kimmel-cancer-center
Details last updated 05-May-2025
First-line nivolumab doubles typical response rates in inoperable basal cell carcinoma
A new liquid biopsy developed at Johns Hopkins uses machine learning to spot brain tumours